BeOne (ONC) Secured a Pharmaceutical-Tariff Exemption After More than $1B of U.S. Manufacturing Investment. Are the Pricing Concessions Worth It?

September 4, 2026 · 6:44 pm 1 sources

Image: Yahoo Finance

Coverage

More coverage

• BeOne (ONC) Secured a Pharmaceutical-Tariff Exemption After More than $1B of U.S. Manufacturing Investment. Are the Pricing Concessions Worth It?
  Yahoo Finance · September 4, 2026 18:44